Amphastar Pharmaceuticals Stock News

In a report released today, Serge Belanger from Needham maintained a Buy rating on Collegium Pharmaceutical (COLL), with a price target of $38.00. The

In a report released today, Serge Belanger from Needham maintained a Buy rating on Collegium Pharmaceutical (COLL – Research Report),

Needham analyst Serge Belanger maintained a Buy rating on Aerie Pharma (AERI) today and set a price target of $40.00. The company's shares closed last

Needham analyst Serge Belanger maintained a Buy rating on Aerie Pharma ( AERI – Research Report ) today and set a price target of $40.00 . The company’s shares closed last Monday at $13.50, close

Needham analyst Serge Belanger maintained a Buy rating on Revance Therapeutics (RVNC) today and set a price target of $36.00. The company's shares closed

Needham analyst Serge Belanger maintained a Buy rating on Revance Therapeutics (RVNC – Research Report) today and set a price

Zacks.com featured highlights include: Amphastar Pharmaceuticals, ConforMIS, Kirkland Lake Gold, Cubic and Cimpress

Zacks.com featured highlights include: Amphastar Pharmaceuticals, ConforMIS, Kirkland Lake Gold, Cubic and Cimpress

Bet on these top-ranked stocks with rising P/E to realize outsized gains.

Bet on these top-ranked stocks with rising P/E to realize outsized gains.

Great West Life Assurance Co. Can purchased a new stake in Amphastar Pharmaceuticals Inc (NASDAQ:AMPH) during the fourth quarter, according to its most recent filing with the SEC. The firm purchased 4

Verrica Pharmaceuticals (VRCA) received a Buy rating and a $20.00 price target from Needham analyst Serge Belanger today. The company's shares closed last

Verrica Pharmaceuticals (VRCA – Research Report) received a Buy rating and a $20.00 price target from Needham analyst Serge Belanger